In this present study, we demonstrated the functional expression of CCR5 on CD38+HLA-DR+CD8+ T cells and the presence of CD45RA+CCR7− underling CCR5+CD38+HLA-DR+CD8+ T-cell activation in patients with glioma. This evidence concerns the gene CCR7 and central nervous system cancer.